6821 — Asymchem Laboratories (Tianjin) Co Balance Sheet
0.000.00%
- HK$36.45bn
- HK$27.85bn
- CNY6.67bn
Annual balance sheet for Asymchem Laboratories (Tianjin) Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6,633 | 7,423 | 9,007 | 7,522 | 7,107 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,052 | 2,781 | 2,299 | 2,182 | 2,245 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,310 | 11,860 | 12,352 | 11,050 | 11,506 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,697 | 5,056 | 5,601 | 6,412 | 7,001 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 15,156 | 18,239 | 19,767 | 19,289 | 20,277 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,205 | 2,177 | 1,801 | 1,709 | 1,968 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,546 | 2,592 | 2,287 | 2,443 | 2,642 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 12,610 | 15,647 | 17,480 | 16,845 | 17,635 |
| Total Liabilities & Shareholders' Equity | 15,156 | 18,239 | 19,767 | 19,289 | 20,277 |
| Total Common Shares Outstanding |